NIH working on information on Celebrex use
Key points
- The National Institutes of Health said on Friday it was working with the Food and Drug Administration to make sure the public has information "to make informed decisions" about the use of COX-2 inhibitors like Pfizer Inc.'s Celebrex and Merck & Co.'s withdrawn drug Vioxx.
- "We are examining the use of these agents in all NIH-sponsored clinical studies.
- Meanwhile, acting FDA Commissioner Lester Crawford said on Friday that the agency has "great concerns" about Celebrex and other COX-2 inhibitors.
- The FDA is "keeping all options open" on Celebrex, including the possibility of adding a black box warning about safety risks.
The National Institutes of Health said on Friday it was working with the Food and Drug Administration to make sure the public has information "to make informed decisions" about the use of COX-2 inhibitors like Pfizer Inc.'s Celebrex and Merck & Co.'s withdrawn drug Vioxx.
"We are examining the use of these agents in all NIH-sponsored clinical studies. In addition, we are working closely with our colleagues at FDA to ensure that the public has the information they need to make informed decisions about the use of this class of drug," NIH Director Elias Zerhouni said in a statement.
Meanwhile, acting FDA Commissioner Lester Crawford said on Friday that the agency has "great concerns" about Celebrex and other COX-2 inhibitors.
The FDA is "keeping all options open" on Celebrex, including the possibility of adding a black box warning about safety risks. Crawford said he expected to have more announcements about Celebrex in the next few days.
###
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Medicines & Treatments →Hypertensive patients benefit from acupuncture treatments, UCI study finds
Patients with hypertension treated with acupuncture experienced drops in their blood pressure that lasted up to a month and a half, researchers with the Susan Samueli Center for Integrative Medicine have found. Their…
21 August 2015
